Expression analysis of CYP27B1 in tumor biopsies and cell cultures

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2683-2686

  Radermacher, Jens ^a   Diesel, Britta ^a   Seifert, Markus ^a   Tilgen, Wolfgang ^a   Reichrath, Jörg ^a   Fischer, Ulrike ^a   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

1 ,25(OH)2D3; Alternative splicing; CYP27B1; Extrarenal expression; Glioblastoma multiforme; Melanoma

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 27B1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY PARENCHYMA; LUNG CANCER; LUNG PARENCHYMA; MOLECULAR CLONING; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; THYMUS; TISSUE DISTRIBUTION; TUMOR BIOPSY; TUMOR CELL CULTURE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ALTERNATIVE SPLICING; BIOPSY; BRAIN; CELL LINE, TUMOR; FEMALE; HELA CELLS; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MELANOMA; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 33746599146     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jones G, Ramshaw H, Zhang A, Cook R, Byford V, White J and Petkovich M: Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human non small cell lung carcinomas. Endocrinology 140(7): 3303-3310, 1999.
2. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86(2): 888-894, 2001.
3. Nemere I and Szego CM: Early actions of parathyroid hormone and 1,25-dihydroxycholecalciferol on isolated epithelial cells from rat intestine: I. Limited lysosomal enzyme release and calcium uptake. Endocrinology 108(4): 1450-1462, 1981.
4. Frankel TL, Mason RS, Hersey P, Murray E and Posen S: The synthesis of vitamin D metabolites by human melanoma cells. J Clin Endocrinol Metab 57(3): 627-631, 1983.
5. Bartel F, Harris LC, Wurl P and Taubert H: MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides. Mol Cancer Res 2(1): 29-35, 2004.
6. Roy M, Xu Q and Lee C: Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res 33(16): 5026-5033, 2005.
7. Yamaguchi H, Nakazato M, Miyazato M, Kangawa K and Matsukura S: A 5'-splice site mutation in the cytochrome P450 steroid 17alpha-hydroxylase gene in 17alpha-hydroxylase deficiency. J Clin Endocrinol Metab 82(6): 1934-1938, 1997.
8. Chen W, Kubota S, Teramoto T, Nishimura Y, Yonemoto K and Seyama Y: Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5' splice site at the mutant codon in cerebrotendinous xanthomatosis patients. Biochemistry 37(13): 4420-4428, 1998.
9. Ding S, Lake BG, Friedberg T and Wolf CR: Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem J 306(Pt 1): 161-166, 1995.
10. Gracia E, Fischer U, elKahloun A, Trent JM, Meese E and Meltzer PS: Isolation of genes amplified in human cancers by microdissection mediated cDNA capture. Hum Mol Genet 5(5): 595-600, 1996.
11. Maas RM, Reus K, Diesel B, Steudel WI, Feiden W, Fischer U and Meese E: Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP27B1) in human malignant glioma. Clin Cancer Res 7(4): 868-875, 2001.
12. Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, Reichrath J, Fischer U and Meese E: Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res 11(15): 5370-5380, 2005.
13. 3-1alpha-hydroxylase in brain and skin cancer. J Steroid Biochem Mol Biol 89-90(1-5): 527-532, 2004.
14. Bikle DD, Pillai S and Gee E: Squamous carcinoma cell lines produce 1,25 dihydroxyvitamin D, but fail to respond to its prodifferentiating effect. J Invest Dermatol 97(3): 435-441, 1991.
15. 3. Cancer Epidemiol Biomarkers Prev 7(5): 391-395, 1998.
16. Hewison M, Zehnder D, Bland R and Stewart PM: 1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol 25(2): 141-148, 2000.
17. Zehnder D, Bland R, Walker EA, Bradwell AR, Howie AJ, Hewison M and Stewart PM: Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10(12): 2465-2473, 1999.
18. 3-24- hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells. J Steroid Biochem Mol Biol 89-90(1-5): 115-119, 2004.
19. Hollis BW: 25-Hydroxyvitamin D3-1 alpha-hydroxylase in porcine hepatic tissue: subcellular localization to both mitochondria and microsomes. Proc Natl Acad Sci USA 87(16): 6009-6013, 1990.
20. 3-1alpha- hydroxylase in cervical tissue. Anticancer Res 22(1A): 183-186, 2002.
21. Dusso A, Brown A and Slatopolsky E: Extrarenal production of calcitriol. Semin Nephrol 14(2): 144-155, 1994.
22. 3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations. J Biol Chem 279(9): 7591-7597, 2004.
23. Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH and Lee MP: Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res 63(3): 655-657, 2003.
24. Hentze MW and Kulozik AE: A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96;(3):307-310, 1999.